THE EFFECTIVENESS OF MOTIVATIONAL INTERVIEWING TECHNIQUES IN MOTIVATION TO CHANGE AND AMBIVALENCE AMONG YOUNG ADULTS WITH AMPHETAMINE USE DISORDER

The use of amphetamine disorder in young adults is also linked with low motivation to change and high ambivalence to substance use, which tend to hinder treatment and recovery efforts. Motivational Interviewing (MI) is an evidence-based counselling intervention that is client-focused and aims at improving intrinsic motivation and ambivalence resolution. The Purposive sampling was employed to recruit 30 participants with a clinical diagnosis of amphetamine use disorder who are rehabilitation centers. It was done in a pre-test post test design and a structured MI intervention was given to the subjects through several sessions. Standardized self-report measures were used to measure motivation to change and ambivalence, and the Wilcoxon signed-rank test was used to determine within-group changes. Findings showed that the level of motivation to change changed significantly (p <.01) and that the level of ambivalence towards drug use changed significantly (p <.01) after the MI intervention. The results of these studies indicate that MI is efficient in boosting the motivation processes and the decrease in the psychological barriers to change in young adults with AUDs using amphetamines (Rasool et al., 2021: Rasool et al., 2022,). The research has a practical clinical implication since it has identified MI as a short, affordable, and client-focused intervention that can enhance the engagement of treatment and readiness people to further evidence-based treatments. In spite of the restriction of such elements as small sample size, self-report measures, and absence of long-term follow-up, findings contribute to the empirical evidence of integrating MI into substance use treatment programs. To summarize, Motivational Interviewing shows a great potential to stimulate motivation and decrease ambivalence among young adults with amphetamine use disorder as it can also be used to enhance better therapeutic outcomes and recovery engagement.